Nov. 28 (Bloomberg) -- Bloomberg's Su Keenan reports that on a conference call that acknowledged the firm receiving a Wells Notice from the SEC, SAC Capital Advisors CEO Steven Cohen stated that he acted appropriately while trading shares of drug makers in 2008. She speaks on Bloomberg Television's "Money Moves."
Jan. 28 -- Full episode of "Bloomberg West." Guests: Wealthfront's Ali Rosenthal, Techonomy CEO David Kirkpatrick, Morningstar's RJ Hottovy, HomeAway co-founder Carl Shepherd, NFL Chief Information Officer Michelle McKenna-Doyle, Interana CEO Ann Johnson and Mesa Resource Development and Marketing Director Julian Martinez.
On a Roll: Rolls-Royce Sees Best Year Ever in 2014